HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide (Q55241966)

28 June 2018

title

HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1089/AID.1990.6.1115

3 November 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

3 November 2022

K J Weinhold

1 reference

28 June 2018

Áine McKnight

object named as

A. McKnight

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

P. J. Durda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

L. Bacheler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

P. Clapham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

A. M. Jenoski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

B. Leece

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

T. J. Matthews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

R. Pomerantz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

M. Rayner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702301

3 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1702301

3 November 2022

publication date

1 September 1990

1 reference

28 June 2018

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/aid.1990.6.1115

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1089/AID.1990.6.1115

AIDS Research and Human Retroviruses

3 November 2022

published in

1 reference

28 June 2018

volume

1 reference

28 June 2018

issue

1 reference

28 June 2018

page(s)

1115-1123

1 reference

28 June 2018

describes a project that uses

1 reference

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS.

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

A formalin-inactivated whole SIV vaccine confers protection in macaques

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

8 Use of glutaraldehyde as a coupling agent for proteins and peptides

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Characterization of murine monoclonal antibodies to HIV-1 induced by synthetic peptides

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

The production of more useful monoclonal antibodies I. Modifications of the basic technology

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Variable and conserved neutralization antigens of human immunodeficiency virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Neutralizing monoclonal antibodies to the AIDS virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

Complete nucleotide sequence of the AIDS virus, HTLV-III

3 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1990.6.1115

3 November 2022

Identifiers

DOI

1 reference

28 June 2018

1 reference

28 June 2018